Cytocom
0 followers
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel second-generation immune therapies to deliver immune homeostasis based on proprietary platforms. The company has four phases 3 ready programs in Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer.
Org chart
Michael K. Handley
Collapse
Andrei Gudkov
Global Head of R&D
Stephen Wilson
Global Head of Innovation
Kelly Wilson
Global Director of Program & Project Management
Taunia Markvicka
Chief Operations Officer
Peter Aronstam
Chief Financial Officer
Cozette McAvoy
Chief Legal Officer
Clifford Selsky
Chief Medical Officer
Robert W. Buckheit
Chief Technology Officer
Noreen M. Griffin
Founder; EVP of Corporate Strategy
Ann Hards
EVP of Regulatory Affairs
Yakov Kogan
SVP of Strategy & Alliance
Robert Wilson
VP of Business Intelligence & Strategy
Alex Mond
VP of Corporate Development
Allie Lopez
Senior Director of Clinical Operations
Curt Dewitz
Director of Business Development
James Mendolera
Director of Information Technology
